Back to NRIX
PRICE T ROWE ASSOCIATES INC /MD/ → NRIX
PRICE T ROWE ASSOCIATES INC /MD/ NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
8
Latest value
$4.3M
Q3 2026
Peak value
$127.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $59M |
| Q4 2025 | $2.6M |
| Q1 2026 | $2.4M |
| Q1 2026 | $48.6M |
| Q2 2026 | $127.6M |
| Q2 2026 | $4.3M |
| Q3 2026 | $104.1M |
| Q3 2026 | $4.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.3M | 181.6K | — | — |
| Q3 2026 | $104.1M | 4.39M | — | — |
| Q2 2026 | $4.3M | 176.0K | — | — |
| Q2 2026 | $127.6M | 5.26M | — | — |
| Q1 2026 | $48.6M | 3.13M | — | — |
| Q1 2026 | $2.4M | 155.5K | — | — |
| Q4 2025 | $2.6M | 136.4K | — | — |
| Q4 2025 | $59M | 3.11M | — | — |
Other funds holding NRIX
$195.3M
$187.7M
$187.3M
$175.3M
$166.6M
$164.8M
$153.5M
$142.3M